NEW YORK — Constellation Brands did almost everything right on Tuesday — and the market punished it anyway. The Corona and Modelo maker reported fiscal second-quarter sales of $2.63 billion, up 6% from a year ago and just ahead of analysts’ expectations, with adjusted earnings of $3.74 a share also beating estimates. Shares sank in Wednesday’s premarket trading, down about 5% and on track for their lowest point since early 2020, according to Investopedia. When a stock falls on a double beat, the market is telling you it didn’t like the one number that actually mattered.
The headline numbers were genuinely good. Revenue of $2.63 billion beat consensus estimates of roughly $2.53–2.54 billion, per StockStory and MarketBeat. Comparable, or adjusted, earnings of $3.74 a share topped the $3.55 consensus by 19 cents — a 5.5% beat. On a reported basis, the company made $565.8 million, or $3.32 a share, up from $466 million, or $2.65 a share, a year earlier. That’s 21% net-income growth in a consumer environment where most companies would kill for half of it. For the full market picture this morning, see our pre-open wrap.

DemandDepletions: the number that mattered
Here’s the number that sank the stock. Beer depletions — the metric that tracks shipments to retailers and reads as a real-time indicator of demand — declined in the quarter, according to Investopedia. Everything else in the release said “growth”; depletions whispered “slowdown.” Beer sales, including Corona and Modelo, still rose 5% to $2.474 billion, but investors buy stocks on where demand is going, not where it’s been.
The margin picture didn’t help the mood. Reported operating income declined 8% year over year, and operating margin compressed to 30.6% from 35.2% a year earlier, per StockStory. Beer operating income managed only a 1% increase despite the 5% sales growth — the telltale sign of a business spending more to sell each case. When your biggest segment grows sales but barely grows profit, the market starts asking uncomfortable questions about pricing power.
OutlookThe guidance squeeze
Then came the outlook, and it landed with a thud. Management reaffirmed fiscal 2027 reported EPS guidance of $11.20 to $11.90 — but the comparable midpoint of $11.55 sits below the $11.74 analyst consensus, and full-year revenue guidance of about $9 billion at the midpoint came in 0.9% below estimates, per StockStory. A beat-and-lower is Wall Street’s least favorite genre of earnings report: it says the past was fine and the future is the problem.
To be fair to management, the consumer backdrop is genuinely tough. The company declined to push through widespread price increases as inflation-pinched shoppers pulled back, leaving pricing net of mix roughly flat for the quarter — volume growth drove most of the revenue increase, according to The Drinks Business. That’s a disciplined choice, but it leaves no cushion when volumes wobble.

On-premise vs. off-premiseBeer is holding the line
The quarter had a genuine bright spot, and it came with a soccer ball. Some World Cup-related activity during the quarter boosted beer sales in bars and restaurants, The Drinks Business reports — buoyant on-premise sales counteracted slower demand in the off-trade, where restrained consumer spending kept the shelves quiet. It’s a useful split-screen of the American consumer right now: still willing to buy the round at the bar, still cautious in the grocery aisle.
Wine, spirits, and RTDsBeyond beer
The wine and spirits business — long the problem child of the portfolio — had its best quarter in a while. Sales jumped 17% to $159.4 million, returning the segment to operating profitability after a loss a year earlier. It’s still a small piece of the company, but a profitable small piece beats a loss-making one.
And Constellation is placing a new bet on where drinking is headed: ready-to-drink cocktails. The company announced the acquisition of SpikedAde, a spirit-based, sports-drink-inspired RTD brand, for $75 million at closing with up to $278 million in additional payments over five years tied to performance. It’s a classic Constellation move — buy the growth category early — and it signals where management thinks the next leg of volume comes from. Our earnings-week preview flagged this as the consumer name to watch.
The balance sheet gives management room to maneuver. Year-to-date free cash flow reached roughly $1.1 billion, the company repurchased $530 million of stock, and it declared a $1.03 quarterly dividend. Buybacks and dividends don’t fix depletions, but they do tell you management thinks the selloff is overdone.

The tapeWhat investors are watching
The market’s message was blunt: beats don’t matter when the demand signal is flashing yellow. With the stock’s 52-week low at $110.60 and shares trading well below their 200-day moving average, per MarketBeat, Constellation has gone from market darling to show-me story. The next data point that matters isn’t another earnings beat — it’s depletions stabilizing. Until then, the company behind two of America’s biggest beer brands will keep fighting the suspicion that America is drinking a little less of them.
Sources
- Investopedia — Constellation Brands Q2: $2.63B sales (+6%), adjusted EPS $3.74; beer depletions declined; SpikedAde acquisition $75M plus $278M; shares down 5% in Wednesday premarket trading toward lowest since early 2020. Oct 7, 2026
- StockStory — Revenue $2.63B vs $2.53B est (+6.1%); adjusted EPS $3.74 vs $3.55; full-year revenue guidance ~$9B (0.9% below est); comparable EPS guidance $11.55 midpoint vs $11.74 consensus; operating margin 30.6% vs 35.2%. Oct 6, 2026
- The Drinks Business — Q2 revenue +6% to $2.63B; beer +5%, wine and spirits +17%; net income $565.8M; World Cup activity boosted on-premise beer sales; pricing flat; SpikedAde RTD acquisition. Oct 6, 2026



